Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03824704
Title A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES)
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Clovis Oncology, Inc.

ovary epithelial cancer

fallopian tube cancer

peritoneum cancer


Nivolumab + Rucaparib

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.